Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-25-008317
Filing Date
2025-03-05
Accepted
2025-03-05 16:37:22
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 6013
  Complete submission text file 0001127602-25-008317.txt   7439
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Issuer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Guerrero Ramiro (Reporting) CIK: 0001913253 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41455 | Film No.: 25711816